Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations
1 clinical trials · Condition
◉ Watch Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations (NCT02674750) | Curis, Inc. | 2016-07-01 |
Track Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations automatically
Every clearance here is in the API, with alerts when new ones post.